-
Mashup Score: 1Dravet Syndrome Clinical Trial With STK-001 Continues - 1 year(s) ago
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study, which is evaluating STK-001 in patients with Dravet syndrome.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Dravet Syndrome Clinical Trial With STK-001 Continues - 1 year(s) ago
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study, which is evaluating STK-001 in patients with Dravet syndrome.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study evaluating STK-001 in patients with Dravet syndrome. https://t.co/Y8K9aJW7Jj @StokeTx @curedravet @DSFeu @DravetUK @NIH #DravetSyndrome #StokeTherapeutics #raredisease
-
-
Mashup Score: 0Dravet Syndrome Clinical Trial With STK-001 Continues - 1 year(s) ago
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study, which is evaluating STK-001 in patients with Dravet syndrome.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study evaluating STK-001 in patients with Dravet syndrome. https://t.co/Y8K9aJW7Jj @StokeTx @curedravet @DSFeu @DravetUK @NIH #DravetSyndrome #StokeTherapeutics #raredisease
-
-
Mashup Score: 1Dravet Syndrome Clinical Trial With STK-001 Continues - 1 year(s) ago
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study, which is evaluating STK-001 in patients with Dravet syndrome.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study evaluating STK-001 in patients with Dravet syndrome. https://t.co/Y8K9aJW7Jj @StokeTx @curedravet @DSFeu @DravetUK @NIH #DravetSyndrome #StokeTherapeutics #raredisease
-
-
Mashup Score: 0Dravet Syndrome Clinical Trial With STK-001 Continues - 1 year(s) ago
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study, which is evaluating STK-001 in patients with Dravet syndrome.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study evaluating STK-001 in patients with Dravet syndrome. https://t.co/Y8K9aJW7Jj @StokeTx @curedravet @DSFeu @DravetUK @NIH #DravetSyndrome #StokeTherapeutics #raredisease
-
-
Mashup Score: 1Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
Via @GreenJournal: Children with #DravetSyndrome should be prioritized to receive the #influenza #vaccine because of their high susceptibility for developing neurologic complications and sequelae: https://t.co/V1bBSVDRax #neurology #neurotwitter #flu @AANMember https://t.co/5madAM5D1h
-
-
Mashup Score: 0Dravet Syndrome Clinical Trial With STK-001 Continues - 1 year(s) ago
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study, which is evaluating STK-001 in patients with Dravet syndrome.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study evaluating STK-001 in patients with Dravet syndrome. https://t.co/Y8K9aKdIAR @StokeTx @curedravet @DSFeu @DravetUK @NIH #DravetSyndrome #StokeTherapeutics #raredisease
-
-
Mashup Score: 0The Value of Family Support When Living with Dravet Syndrome - Child Neurology Foundation - 1 year(s) ago
Charlotte Martinez, 17 years old, experienced her first seizure at 4 months old and was diagnosed with Dravet syndrome in 2006 when she was nearly…
Source: Child Neurology FoundationCategories: Latest Headlines, NeurologyTweet-
Charlotte Martinez, 17 years old, experienced her first seizure at 4 months old and was diagnosed with Dravet syndrome in 2006 when she was nearly 2. Learn about Dravet syndrome and how family support helped Martinez here: https://t.co/ZmAXcntAku #DravetSyndrome #FamilySupport https://t.co/N7RE8t1IWD
-
-
Mashup Score: 0‘Yes, awareness matters… and where better to start than with nurses?’ | Nursing Times - 2 year(s) ago
Paediatric epilepsy clinical nurse specialist Amanda Tomalin on Dravet Syndrome and the importance of international awareness days.
Source: Nursing TimesCategories: Latest Headlines, NursingTweet-
.@EvelinaLondon paediatric epilepsy clinical nurse specialist Amanda Tomalin on #DravetSyndrome and the importance of international awareness days https://t.co/jUrStl5v0z
-
-
Mashup Score: 8Guidance on Dravet Syndrome from Infant to Adult Care: Road Map for Treatment Planning in Europe - 2 year(s) ago
Dravet syndrome (DS) is a severe, rare and complex developmental and epileptic encephalopathy affecting 1 in 16’000 live births and characterized by a drug resistant epilepsy, cognitive, psychomotor …
Source: Wiley Online LibraryCategories: Latest Headlines, NeurologyTweet-
Guidance on Dravet Syndrome from Infant to Adult Care: Road Map for Treatment Planning in Europe https://t.co/K27WKpa7wQ CRITICAL REVIEW #epilepsy #dravetsyndrome #antiseizuremed @IlaeWeb @yesILAE @WileyNeuro https://t.co/j5oISnPNMN
-
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study evaluating STK-001 in patients with Dravet syndrome. https://t.co/Y8K9aJW7Jj @StokeTx @curedravet @DSFeu @DravetUK @NIH #DravetSyndrome #StokeTherapeutics #raredisease